News and Announcements
Bulletproof FY16 Results: Revenue up 67%, Closing Balance of $4.6m
- Published July 14, 2016 4:58PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
14th July 2016, ASX Announcement
FY16 Results Guidance
- Full year revenues expected to be in line with market expectations $47m, up 67% on FY15
- Underlying EBITDA expected to be $4.6m – $4.7, up from $4.2 in FY15
- Underlying EBIT expected to be $600k – $700k, down from $850k in FY15
- Positive operating cashflow, with closing cash balance of $4.6m
Bulletproof wishes to advise the market of its expected FY16 full year results and trading conditions with this interim update.
FY16 Results
The ongoing investment in accelerated growth from organic and acquired revenue sources is expected to deliver a revenue figure in line with market expectations, at $47m, a 67% increase on FY15, and well above market revenue growth rates of 25-30%. Of this revenue, recurring sources are expected to make up close to 80% of the total figure. Cash flow is positive for the year, with a closing cash balance of $4.6m.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
